New Developments in Myeloma Treatment and Response Assessment.

导出 OA

翻译打印收藏纠错

作者： Françoise,Kraeber-Bodéré ^[1] ; Bastien,Jamet ^[2] ; Davide,Bezzi ^[3] ; Elena,Zamagni ^[4] ; Philippe,Moreau ^[5] ; Cristina,Nanni ^[6]

作者单位： Médecine nucléaire, CHU Nantes, Nantes Université, Université Angers, INSERM, CNRS, CRCI2NA, F-44000, Nantes, France. ^[1] Médecine nucléaire, CHU Nantes, F-44000, Nantes, France. ^[2] Department of Nuclear Medicine, Alma Mater Studiorum, University of Bologna, Bologna. Italy. ^[3] IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli," Bologna, Italy. ^[4] Dipartimento di Scienze Mediche e Chirurgiche, Università di Bologna, Bologna, Italy. ^[5] Hématologie, CHU Nantes, Nantes Université, Université Angers, INSERM, CNRS, CRCI2NA, F-44000, Nantes, France; and. ^[6] Nuclear Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy cristina.nanni@aosp.bo.it. ^[7]

关键词 18F-FDG PET/CT 68Ga-pentixafor MRI multiple myeloma radiomics therapeutic evaluation

主题词人类(Humans);多发性骨髓瘤(Multiple Myeloma);氟脱氧葡萄糖F18(Fluorodeoxyglucose F18);前瞻性研究(Prospective Studies);免疫疗法(Immunotherapy)

DOI 10.2967/jnumed.122.264972

PMID 37591548

发布时间 2023-09-07

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交